Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triptorelin Pamoate for Central Precocious Puberty in Chinese Children
CTR20210223Phase 3Completed
- Sponsor
- Ipsen
- Start
- Mar 2021
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of triptorelin in central precocious puberty (CPP), sponsored by Ipsen. Started Mar 2021; status: completed.
02
Drugs
triptorelin
03
Conditions
central precocious puberty (CPP)
Beyond the preview
Go deeper on CTR20210223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20210223.